Ʈ (LEVITRA)
ܴ ߱
Ϲ ߱ ȯ 800 翡 Ʈ ߱ ְ
58% 18% ̻ ϴ Ÿ. (Journal of Sexual Medicine,2004.9.)
500 ߱ ȯ Ʈ ߱Ⱝ 鿡 42% ,
37% 21% ٸ ǰ(Ʊ, þ˸) ռ Ǿ.
(11ȸ ISSIR, ߱ ȸ, 纥 к Ʋ̽ ڻ)
40 ̻ 70% '߱ġ Ư' 'ܴ ߱'
߿ϴٰ ߴ. (̿,2004)
ǻ 200 翡 ü ǻ 52% '߱ '
ǰ Ʈ ߴ. (̿,2004)
ۿ ð
Ʈ 10-60к ȿ ϱ Ͽ 12ð ȿ ȴ.
Ʈ Ǵ ߱ ġ PDE5 , ִ
ð .
ð ȿ ߱Ⱑ ϹǷ ȯڵ ٸ .
ġϱ ߱ ȯڿԵ ȿ 1 ġ
索 ִ ߱ ȯ 72% ߱ɷ ( 13%, ADA)
ü ȯٵ 71% ߱ɷ ( 12%)
ô ջ ߱ δ ȯ 80% ߱ɷ ( 26% RESPITE)
ְ ִ ߱ ȯ 83% ߱ɷ ( 30%, DRIVER)
Ʈ ȯ , ΰ ߱ɷ
ߵ PDE5
ٵ ǵ(Ʊ) 10 PDE-5 ɷ
ٵ ߱ ߰ߵǴ ߱ ȿ PDE5 ۿ
Ʈ κ ȯڵ 迡
̾ ȯڱ Ʈ ȯڴ ߱ð 3
Ʈ (Baseline) , Ʈ 3
ϰ ȯڵ鿡 Ƚ
༺
3,750 ̻ ӻ Ʈ Ͽ,
2001 11 730 ̻ 1 ̻ Ʈ
Ϲ ̻ ȭҷ, , κ Ͻ̰ ̾
ȸ ȫ PDE-5 ִ ̸̻ ӻ
̻ Ͽ Ʈ ߴ ȯڴ 3.% Ұ(౺ 1.4%)
ȿ,ȿ
Ʈ ڱ ִ 쿡 ȿ ֵ˴ϴ.
ȿ 밳 15~30п Ÿ 4-5ð ȿ ӵ˴ϴ.( )
20п 1ð ϴ° Ǿ 1-2ð ϼŵ ˴ϴ.
Ʊ ȿ ġ ĻĿ
ϵǾ ߱ȿ ణ ʰ Ͼ ֽϴ.
ǻ
Ʈ ϴ ȯ Ϻο ȸȫ ڸ ȭҷ αٰŸ
ֽϴ. κ Ͻ̸ ؼ ̷ п ϴ
κ ϴ. Ʈ ѴϿ ߵ
ߴѴص ߱ ٴ ̴ ߱¿
ɸ ڽŰ ȸ Դϴ.